US$ 24.81
retatrutide dosing trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Dosing: Early Clinical Trial
Description
There is one documented exception

D., & Rancao, K

That's impressive when you compare it to existing GLP-1 drugs such as Ozempic and Wegovy, which use semaglutide, or Mounjaro and Zepbound, which use tirzepatide

Up to -16.9% weight loss

Are compounded GLP-1 medications safe and effective
